All 4,687 procedure codes billed by Medicaid providers in Ohio, ranked by total spending.
| # | Code | Description | Total Paid |
|---|---|---|---|
| 1 | T1019 | Personal care services, per 15 minutes, not for an inpatient or resident of a hospital, nursing facility, icf/mr or imd, part of the individualized plan of treatment (code may not be used to identify services provided by home health aide or certified nurse assistant) | $2.58B |
| 2 | 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | $1.71B |
| 3 | 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | $1.65B |
| 4 | H2019 | Therapeutic behavioral services, per 15 minutes | $1.51B |
| 5 | T2046 | Hospice long term care, room and board only; per diem | $1.32B |
| 6 | G0156 | Services of home health/hospice aide in home health or hospice settings, each 15 minutes | $1.22B |
| 7 | H0015 | Alcohol and/or drug services; intensive outpatient (treatment program that operates at least 3 hours/day and at least 3 days/week and is based on an individualized treatment plan), including assessment, counseling; crisis intervention, and activity therapies or education | $1.18B |
| 8 | 90837 | Psychotherapy, 53 minutes with patient | $1.08B |
| 9 | 99284 | Emergency department visit for the evaluation and management, high severity | $969.23M |
| 10 | G0463 | Hospital outpatient clinic visit for assessment and management of a patient | $889.69M |
| 11 | 99283 | Emergency department visit for the evaluation and management, moderate severity | $885.97M |
| 12 | T1015 | Clinic visit/encounter, all-inclusive | $825.24M |
| 13 | 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | $736.41M |
| 14 | H2036 | Alcohol and/or other drug treatment program, per diem | $681.69M |
| 15 | H0036 | Community psychiatric supportive treatment, face-to-face, per 15 minutes | $492.11M |
| 16 | T1000 | Private duty / independent nursing service(s) - licensed, up to 15 minutes | $485.59M |
| 17 | H2020 | Therapeutic behavioral services, per diem | $452.83M |
| 18 | 96361 | Intravenous infusion, hydration; each additional hour | $429.20M |
| 19 | H0011 | Alcohol and/or drug services; acute detoxification (residential addiction program inpatient) | $349.26M |
| 20 | G0299 | Direct skilled nursing services of a registered nurse (rn) in the home health or hospice setting, each 15 minutes | $305.22M |
| 21 | H0020 | Alcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program) | $301.43M |
| 22 | G0300 | Direct skilled nursing services of a licensed practical nurse (lpn) in the home health or hospice setting, each 15 minutes | $298.63M |
| 23 | 90999 | Unlisted dialysis procedure, inpatient or outpatient | $287.83M |
| 24 | T2031 | Assisted living; waiver, per diem | $275.53M |
| 25 | S5170 | Home delivered meals, including preparation; per meal | $262.62M |
| 26 | 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | $221.18M |
| 27 | H0006 | Alcohol and/or drug services; case management | $219.38M |
| 28 | 90834 | Psychotherapy, 45 minutes with patient | $195.63M |
| 29 | E2510 | Speech generating device, synthesized speech, permitting multiple methods of message formulation and multiple methods of device access | $192.90M |
| 30 | T1502 | Administration of oral, intramuscular and/or subcutaneous medication by health care agency/professional, per visit | $185.54M |
| 31 | 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | $185.09M |
| 32 | A0427 | Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) | $184.54M |
| 33 | 90832 | Psychotherapy, 30 minutes with patient | $183.18M |
| 34 | 70450 | Computed tomography, head or brain; without contrast material | $181.88M |
| 35 | 74177 | Computed tomography, abdomen and pelvis; with contrast material | $169.63M |
| 36 | S5000 | Prescription drug, generic | $168.90M |
| 37 | 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | $158.63M |
| 38 | U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | $151.71M |
| 39 | 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | $140.65M |
| 40 | 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | $136.60M |
| 41 | 97530 | Therapeutic activities, direct patient contact, each 15 minutes | $133.71M |
| 42 | H0005 | Alcohol and/or drug services; group counseling by a clinician | $133.12M |
| 43 | D7140 | Extraction, erupted tooth or exposed root | $133.10M |
| 44 | 99215 | Prolong outpt/office vis | $131.27M |
| 45 | 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | $129.79M |
| 46 | A9276 | Sensor; invasive (e.g., subcutaneous), disposable, for use with non-durable medical equipment interstitial continuous glucose monitoring system, one unit = 1 day supply | $126.61M |
| 47 | A0429 | Ambulance service, basic life support, emergency transport (bls-emergency) | $123.48M |
| 48 | 99282 | Emergency department visit for the evaluation and management, low to moderate severity | $123.00M |
| 49 | H2017 | Psychosocial rehabilitation services, per 15 minutes | $121.19M |
| 50 | T2042 | Hospice routine home care; per diem | $117.80M |
| 51 | E1390 | Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate | $112.45M |
| 52 | J9271 | Injection, pembrolizumab, 1 mg | $110.65M |
| 53 | 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | $108.38M |
| 54 | 90791 | Psychiatric diagnostic evaluation | $106.93M |
| 55 | 99232 | Subsequent hospital care, per day, moderate complexity | $105.52M |
| 56 | 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | $101.45M |
| 57 | 80053 | Comprehensive metabolic panel | $96.93M |
| 58 | 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | $92.79M |
| 59 | 92508 | Group treatment of speech, language, voice, communication, and/or auditory processing disorder | $91.53M |
| 60 | D2930 | Prefabricated stainless steel crown - primary tooth | $90.41M |
| 61 | J2350 | Injection, ocrelizumab, 1 mg | $90.12M |
| 62 | 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | $89.43M |
| 63 | 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | $86.35M |
| 64 | V2020 | Frames, purchases | $84.67M |
| 65 | G0378 | Hospital observation service, per hour | $82.03M |
| 66 | D1110 | Prophylaxis - adult | $78.88M |
| 67 | 99233 | Prolong inpt eval add15 m | $78.78M |
| 68 | D2392 | Resin-based composite - two surfaces, posterior, primary or permanent | $78.08M |
| 69 | 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | $77.43M |
| 70 | 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | $75.94M |
| 71 | H0048 | Alcohol and/or other drug testing: collection and handling only, specimens other than blood | $75.66M |
| 72 | 96110 | Developmental screening, with scoring and documentation, per standardized instrument | $75.08M |
| 73 | 90460 | Immunization administration through 18 years of age via any route, first or only component | $74.94M |
| 74 | 97153 | Adaptive behavior treatment by protocol, administered by technician, each 15 minutes | $73.27M |
| 75 | 74176 | Computed tomography, abdomen and pelvis; without contrast material | $72.88M |
| 76 | H2034 | Alcohol and/or drug abuse halfway house services, per diem | $70.06M |
| 77 | D0120 | Periodic oral evaluation - established patient | $69.13M |
| 78 | A0428 | Ambulance service, basic life support, non-emergency transport, (bls) | $68.63M |
| 79 | H0040 | Assertive community treatment program, per diem | $66.95M |
| 80 | A0425 | Ground mileage, per statute mile | $66.40M |
| 81 | G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | $66.37M |
| 82 | D8670 | Periodic orthodontic treatment visit | $65.54M |
| 83 | T2022 | Case management, per month | $64.48M |
| 84 | E0784 | External ambulatory infusion pump, insulin | $63.72M |
| 85 | 88305 | Level IV - Surgical pathology, gross and microscopic examination | $62.74M |
| 86 | D0150 | Comprehensive oral evaluation - new or established patient | $62.59M |
| 87 | D0330 | Panoramic radiographic image | $58.60M |
| 88 | A4230 | Infusion set for external insulin pump, non needle cannula type | $58.58M |
| 89 | 84443 | Thyroid stimulating hormone (TSH) | $58.50M |
| 90 | T1016 | Case management, each 15 minutes | $58.02M |
| 91 | D1120 | Prophylaxis - child | $57.90M |
| 92 | W1793 | State-specific procedure code | $57.39M |
| 93 | G0151 | Services performed by a qualified physical therapist in the home health or hospice setting, each 15 minutes | $57.34M |
| 94 | 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | $56.81M |
| 95 | T1002 | Rn services, up to 15 minutes | $55.55M |
| 96 | 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | $54.66M |
| 97 | 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | $54.18M |
| 98 | D2391 | Resin-based composite - one surface, posterior, primary or permanent | $52.36M |
| 99 | 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | $51.62M |
| 100 | 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | $51.37M |
| 101 | E0603 | Breast pump, electric (ac and/or dc), any type | $51.19M |
| 102 | 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | $50.45M |
| 103 | 80061 | Lipid panel | $50.31M |
| 104 | 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | $49.46M |
| 105 | 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | $48.90M |
| 106 | 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | $48.02M |
| 107 | 96127 | $48.01M | |
| 108 | 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | $47.84M |
| 109 | H0010 | Alcohol and/or drug services; sub-acute detoxification (residential addiction program inpatient) | $46.81M |
| 110 | 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | $44.93M |
| 111 | H0014 | Alcohol and/or drug services; ambulatory detoxification | $44.64M |
| 112 | H0038 | Self-help/peer services, per 15 minutes | $43.90M |
| 113 | 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | $43.36M |
| 114 | V2103 | Spherocylinder, single vision, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens | $43.26M |
| 115 | 71275 | Computed tomographic angiography, chest, with contrast material | $42.95M |
| 116 | 92551 | $42.16M | |
| 117 | B4161 | Enteral formula, for pediatrics, hydrolyzed/amino acids and peptide chain proteins, includes fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit | $41.48M |
| 118 | J2315 | Injection, naltrexone, depot form, 1 mg | $41.35M |
| 119 | V2784 | Lens, polycarbonate or equal, any index, per lens | $41.29M |
| 120 | E0466 | Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell) | $41.16M |
| 121 | 90853 | Group psychotherapy (other than of a multiple-family group) | $41.10M |
| 122 | J0585 | Injection, onabotulinumtoxina, 1 unit | $41.05M |
| 123 | 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | $40.86M |
| 124 | 99223 | Prolong inpt eval add15 m | $40.05M |
| 125 | 99309 | Subsequent nursing facility care, per day, low to moderate complexity | $39.62M |
| 126 | G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | $39.23M |
| 127 | A0431 | Ambulance service, conventional air services, transport, one way (rotary wing) | $38.78M |
| 128 | 59025 | Fetal non-stress test | $38.72M |
| 129 | 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | $38.45M |
| 130 | E0465 | Home ventilator, any type, used with invasive interface, (e.g., tracheostomy tube) | $38.41M |
| 131 | 90847 | Family psychotherapy with the patient present, 50 minutes | $38.40M |
| 132 | T1003 | Lpn/lvn services, up to 15 minutes | $37.49M |
| 133 | 95810 | Polysomnography; sleep staging with 4 or more additional parameters | $36.89M |
| 134 | E0601 | Continuous positive airway pressure (cpap) device | $36.13M |
| 135 | 98941 | Chiropractic manipulative treatment; spinal, 3-4 regions | $36.08M |
| 136 | D1351 | Sealant - per tooth | $36.08M |
| 137 | 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | $36.07M |
| 138 | S5165 | Home modifications; per service | $35.38M |
| 139 | S5102 | Day care services, adult; per diem | $35.29M |
| 140 | 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | $35.11M |
| 141 | A9277 | Transmitter; external, for use with non-durable medical equipment interstitial continuous glucose monitoring system | $34.20M |
| 142 | G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | $33.30M |
| 143 | 80050 | General health panel | $33.12M |
| 144 | 83036 | Hemoglobin; glycosylated (A1C) | $32.91M |
| 145 | K1034 | Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count | $32.75M |
| 146 | 80048 | Basic metabolic panel (calcium, ionized) | $32.66M |
| 147 | D0274 | Bitewings - four radiographic images | $32.23M |
| 148 | D2393 | Resin-based composite - three surfaces, posterior, primary or permanent | $32.05M |
| 149 | A0130 | Non-emergency transportation: wheelchair van | $32.04M |
| 150 | S9340 | Home therapy; enteral nutrition; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (enteral formula and nursing visits coded separately), per diem | $31.96M |
| 151 | 71046 | Radiologic examination, chest; 2 views | $31.69M |
| 152 | 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | $31.18M |
| 153 | 99308 | Subsequent nursing facility care, per day, straightforward | $30.69M |
| 154 | T4541 | Incontinence product, disposable underpad, large, each | $30.39M |
| 155 | E2617 | Custom fabricated wheelchair back cushion, any size, including any type mounting hardware | $30.25M |
| 156 | 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | $30.15M |
| 157 | E2609 | Custom fabricated wheelchair seat cushion, any size | $29.89M |
| 158 | 41899 | Unlisted procedure, dentoalveolar structures | $29.84M |
| 159 | 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | $29.57M |
| 160 | B4035 | Enteral feeding supply kit; pump fed, per day, includes but not limited to feeding/flushing syringe, administration set tubing, dressings, tape | $29.46M |
| 161 | D1208 | Topical application of fluoride, excluding varnish | $29.32M |
| 162 | E1007 | Wheelchair accessory, power seating system, combination tilt and recline, with mechanical shear reduction | $29.31M |
| 163 | E1161 | Manual adult size wheelchair, includes tilt in space | $29.29M |
| 164 | T2023 | Targeted case management; per month | $28.59M |
| 165 | J3490 | Unclassified drugs | $28.36M |
| 166 | T4527 | Adult sized disposable incontinence product, protective underwear/pull-on, large size, each | $28.05M |
| 167 | 36415 | Collection of venous blood by venipuncture | $27.56M |
| 168 | 71045 | Radiologic examination, chest; single view | $27.48M |
| 169 | 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | $27.22M |
| 170 | D0140 | Limited oral evaluation - problem focused | $27.06M |
| 171 | 71260 | Computed tomography, thorax, diagnostic; with contrast material | $27.01M |
| 172 | 00170 | Anesthesia for intraoral procedures, including biopsy | $26.69M |
| 173 | D0210 | Intraoral - complete series of radiographic images | $26.55M |
| 174 | 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | $26.19M |
| 175 | H0004 | Behavioral health counseling and therapy, per 15 minutes | $26.06M |
| 176 | D1206 | Topical application of fluoride varnish | $25.90M |
| 177 | J2323 | Injection, natalizumab, 1 mg | $25.86M |
| 178 | V2100 | Sphere, single vision, plano to plus or minus 4.00, per lens | $25.80M |
| 179 | K0553 | Supply allowance for therapeutic continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service | $25.66M |
| 180 | G0152 | Services performed by a qualified occupational therapist in the home health or hospice setting, each 15 minutes | $25.44M |
| 181 | T4528 | Adult sized disposable incontinence product, protective underwear/pull-on, extra large size, each | $25.28M |
| 182 | T2029 | Specialized medical equipment, not otherwise specified, waiver | $24.84M |
| 183 | J0178 | Injection, aflibercept, 1 mg | $24.55M |
| 184 | 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | $24.39M |
| 185 | B4160 | Enteral formula, for pediatrics, nutritionally complete calorically dense (equal to or greater than 0.7 kcal/ml) with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit | $24.39M |
| 186 | 45380 | Colonoscopy, flexible; with biopsy, single or multiple | $24.38M |
| 187 | 77386 | $24.00M | |
| 188 | 81420 | Fetal chromosomal aneuploidy genomic sequence analysis panel | $23.85M |
| 189 | T4535 | Disposable liner/shield/guard/pad/undergarment, for incontinence, each | $23.74M |
| 190 | E2402 | Negative pressure wound therapy electrical pump, stationary or portable | $23.66M |
| 191 | 92015 | Determination of refractive state | $23.25M |
| 192 | T4526 | Adult sized disposable incontinence product, protective underwear/pull-on, medium size, each | $23.07M |
| 193 | 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | $23.03M |
| 194 | E0570 | Nebulizer, with compressor | $22.82M |
| 195 | T1001 | Nursing assessment / evaluation | $22.69M |
| 196 | 20610 | $22.63M | |
| 197 | 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | $22.25M |
| 198 | 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | $22.16M |
| 199 | 90792 | Psychiatric diagnostic evaluation with medical services | $21.88M |
| 200 | 90785 | $21.75M |